Activist Biglari Capital Intensifies Proxy Fight, Citing "Disastrous" Q1 Earnings to Oust Chairman Goebel
JACK sits 20% above its 52-week low of $13.993.
Summary
Activist investor Biglari Capital Corp. issued a press release criticizing Jack in the Box's Q1 earnings and urging shareholders to vote against the re-election of Chairman David Goebel, blaming him for significant shareholder value destruction.
Key Events · Corporate Governance and Compliance · JACK
-
Proxy Contest Escalation
Biglari Capital Corp., the largest shareholder with a 9.86% stake, intensified its campaign against the re-election of Chairman David Goebel.
-
Criticism of Q1 Earnings
Biglari cited the recently reported "disastrous" Q1 2026 results, including a 6.7% decline in systemwide same-store sales, a 23% drop in Adjusted EBITDA, and a 54% decrease in EPS from continuing operations.
-
Share Price Impact Highlighted
The activist noted an 18% decline in Jack in the Box's share price following the Q1 earnings announcement (February 18-19, 2026).
-
Blame on Chairman Goebel
Biglari accused Chairman Goebel of massive shareholder value destruction, citing over $1.2 billion lost since he became chairman in June 2020.
Analysis · JACK · Trade & Services
This filing marks a significant escalation in the ongoing proxy contest, with Biglari Capital directly linking the company's recent "disastrous" Q1 financial performance to its call for the removal of Chairman David Goebel. The activist investor highlights a sharp decline in same-store sales, adjusted EBITDA, and EPS, alongside an 18% drop in share price post-earnings. This move puts immense pressure on the current board and management ahead of the annual meeting, as shareholders will be forced to weigh the company's recent poor results against the incumbent leadership. The outcome of this vote could significantly alter the company's strategic direction.
At the time of this filing, JACK was trading at $16.83 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $320.4M. The 52-week trading range was $13.99 to $41.09. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.